Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025

• Big Pharma has spent nearly $150 billion on mergers and acquisitions in 2025, indicating a robust activity in the biotech sector. The current edition of InnovationRx discusses this trend alongside other significant industry developments.
• This surge in M&A activity reflects the industry's aggressive strategy to consolidate resources and innovate, which could lead to advancements in biotechnology and healthcare solutions.

— via World Pulse Now AI Editorial System